logo

BIOA

BioAge LabsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

BIOA Profile

Bioage Labs, Inc.

A biotech company focused on assessing and optimizing biological age

Pharmaceutical
04/01/2015
09/26/2024
NASDAQ Stock Exchange
62
12-31
Common stock
5885 Hollis St, Suite 370, Emeryville, CA 94608
--
BioAge Labs, Inc., was incorporated in Delaware on April 1, 2015. They are a clinical-stage biopharmaceutical company developing product candidates for the treatment of metabolic diseases such as obesity by targeting the biology of human aging. Their technology platform and differentiated human datasets allow them to identify promising targets based on insights into the molecular changes that drive aging. Their main focus is metabolic disease, one of the biggest healthcare challenges in the world.